A randomized controlled trial is evaluating a novel intensive lifestyle intervention against standard care for reducing fasting blood glucose in adults with prediabetes. The primary outcome is the mean change in fasting blood glucose after 6 months. Initial sample size calculations indicate that 300 participants are required to provide 80% statistical power to detect a 10 mg/dL difference between groups, using a two-sided of 0.05 and an anticipated standard deviation (SD) of 20 mg/dL.
Prior to patient enrollment, the central laboratory transitions to a new, highly precise point-of-care assay. A pilot validation study confirms that this new assay reduces the anticipated SD of the fasting blood glucose measurements from 20 mg/dL to 10 mg/dL. The investigators decide to proceed with the originally planned sample size of 300 participants without altering the level.
Assuming the true effect size remains 10 mg/dL, which of the following best describes the statistical impact of utilizing the new laboratory assay?
- AThe primary outcome must now be analyzed using a Chi-square test rather than a Student's t-test.
- BThe positive predictive value of a statistically significant finding will become independent of the pre-test probability of the intervention's efficacy.
- CThe probability of committing a Type I () error will decrease because of the reduced measurement variability.
- The probability of committing a Type II () error will decrease.Answer
- EThe increased precision will allow researchers to interpret baseline demographic confounders as effect modifiers.